EML4-ALK fusion variant V3 is a high-risk feature...

International Journal of Cancer 2018 / 01

EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK + NSCLC

Christopoulos, Petros, Endris, Volker, Bozorgmehr, Farastuk, Elsayed, Mei, Kirchner, Martina, Ristau, Jonas, Buchhalter, Ivo, Penzel, Roland, Herth, Felix J., Heussel, Claus P., Eichhorn, Martin, Mule
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.31275
Date:
January, 2018
File:
PDF, 1.20 MB
english, 2018
Conversion to is in progress
Conversion to is failed